Polypharmacy (Individuals Treated With 4 or More Medications)
Conditions
Keywords
Berg Balance Scale, Cognitive Vestibular Scale, Balance, Geriatric Individual, Mini-Mental State Examination, Polypharmacy
Brief summary
This study aims to evaluate the effects of polypharmacy on balance, fall risk, cognitive status, vestibular function, and hearing among individuals living in nursing homes. The study investigates the relationship between polypharmacy and balance, fall risk, cognitive, vestibular, and hearing-related outcomes.
Detailed description
This study aims to investigate the effects of polypharmacy on balance, fall risk, cognitive status, vestibular function, and hearing in individuals living in nursing homes. The study will evaluate the potential relationships between polypharmacy and cognitive status, balance performance, fall risk, vestibular functions, and hearing outcomes. Participants will undergo detailed assessments (Standardized Mini-Mental State Examination, Berg Balance Scale, Tinetti Test, Timed Up and Go Test, Functional Reach Test, Cognitive Vestibular Function Scale, and pure tone audiometry); the findings will be compared with control group data and analyzed.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Individuals aged 60 years and older * Individuals living in nursing homes in Samsun * Individuals in the polypharmacy group using the defined number of medications and individuals in the control group using fewer or no medications * Ability to walk independently without an assistive device * Ability to communicate verbally * Voluntary participation in the study * No complaint or diagnosis of vestibular disorder * Ability to read and write
Exclusion criteria
* Individuals younger than 60 years * Severe dementia * Use of an assistive walking device * Central nervous system or visual pathologies that may affect balance * Previous diagnosis of vestibular pathology * History of severe neurological diseases such as stroke * Inability to provide reliable responses to the assessments * Inability to cooperate with the assessment procedures * Inability to read and write
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Standardized Mini-Mental State Examination | Baseline | Description: Individuals' cognitive status was assessed using the Standardized Mini-Mental State Examination and compared between the polypharmacy group and the control group. |
| Cognitive-Vestibular Function Scale | Baseline | Individuals' cognitive-vestibular functions were assessed using the Cognitive-Vestibular Function Scale and compared between the polypharmacy group and the control group. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 6-Meter Walk Test | Baseline | Description: Individuals' gait speed was assessed using the 6-Meter Walk Test and compared between the polypharmacy group and the control group. |
| Functional Reach Test | Baseline | Description: Individuals' dynamic balance and functional reach performance were assessed using the Functional Reach Test and compared between the polypharmacy group and the control group. |
| Timed Up and Go Test | Baseline | Description: Individuals' functional mobility and fall risk were assessed using the Timed Up and Go Test and compared between the polypharmacy group and the control group. |
| Tinetti Balance and Gait Test | Baseline | Description: Individuals' balance and gait performance were assessed using the Tinetti Balance and Gait Test and compared between the polypharmacy group and the control group. |
| Berg Balance Scale | Baseline | Description: Individuals' balance performance was assessed using the Berg Balance Scale and compared between the polypharmacy group and the control group. |
Countries
Turkey (Türkiye)
Contacts
Ondokuz Mayıs University